Dallegri F, Ballestrero A, Ottonello L, Patrone F
First Medical Clinic, University of Genova Medical School, Italy.
Thromb Haemost. 1989 Jun 30;61(3):415-8.
Platelets (PLTs) were found to inhibit the chemiluminescence (CL) response of neutrophils (neutrophilic polymorphonuclear leukocytes, PMNs) activated with phorbol myristate acetate. The inhibition of the PMN CL response could be efficiently prevented by pulsing PLTs with carmustine (BCNU) to block their glutathione cycle. In ancillary experiments, the CL response of PMNs was inhibited by catalase (H2O2-scavenger), -azide (myeloperoxidase-MPO-inhibitor), taurine (hypochlorous acid-HOCl-scavenger) and chloride ion omission. These data suggest that the PMN CL response requires the HOCl production by the following pathway: H2O2 + Cl--MPO----H+ HOCl + H2O. Therefore, the BCNU-preventable PLT-induced inhibition of CL may reflect the consumption of PMN-derived H2O2 by the PLT glutathione cycle with a consequent impairment of the HOCl production. Consistent with such a possibility, PLTs lowered the H2O2 and HOCl recovery from PMNs via a BCNU-inhibitable process. Based on these results, we suggest that PLTs have the capacity of limiting the oxidant production by PMNs. This PLT capacity may represent a natural device for the protection of vascular structures from PMN-mediated oxidative stresses.
研究发现,血小板(PLTs)可抑制经佛波酯(PMA)激活的中性粒细胞(嗜中性多形核白细胞,PMNs)的化学发光(CL)反应。用卡莫司汀(BCNU)处理血小板以阻断其谷胱甘肽循环,可有效防止PMN的CL反应受到抑制。在辅助实验中,过氧化氢酶(H2O2清除剂)、叠氮化物(髓过氧化物酶-MPO-抑制剂)、牛磺酸(次氯酸-HOCl-清除剂)和氯离子缺失均可抑制PMN的CL反应。这些数据表明,PMN的CL反应需要通过以下途径产生HOCl:H2O2 + Cl--MPO----H+ HOCl + H2O。因此,BCNU可预防的血小板诱导的CL抑制可能反映了血小板谷胱甘肽循环消耗了PMN衍生的H2O2,从而导致HOCl产生受损。与此可能性一致的是,血小板通过BCNU可抑制的过程降低了PMN中H2O2和HOCl的恢复。基于这些结果,我们认为血小板具有限制PMN产生氧化剂的能力。血小板的这种能力可能是一种保护血管结构免受PMN介导的氧化应激的天然机制。